查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612720

CT/NG 检测市场：按产品类型、技术和最终用户划分 - 2025-2030 年全球预测

CT/NG Testing Market by Product (Assays & Kits, Instruments & Analyzers), Testing Type (Lab Tests, PoC Tests), Technology, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年CT/NG检测市场价值为16.3亿美元，预计到2024年将达到17.4亿美元，复合年增长率为7.41%，预计到2030年将达到26.9亿美元。

由于STD发生率上升和公众健康意识的提高，包括沙眼衣原体和淋病奈瑟菌筛检在内的CT/NG检测披衣菌感染成为人们关注的焦点。这些细菌感染疾病的检测极为重要，因为未经治疗的感染疾病可能会导致严重的生殖健康问题。 CT/NG检测的需求源于其在早期诊断和预防中的重要性，这对降低医疗成本和促进公共卫生安全有直接影响。这些测试主要应用于医院、诊所和诊断实验室，适合性活跃的人，并且由于隐私和便利因素，越来越多地在家庭检测套组中采用。分子诊断技术进步、政府健康措施以及对综合性健康产品不断增长的需求极大地推动了市场成长。主要成长机会集中在开发具有成本效益且高度灵敏的就地检验设备。从区域来看，由于医疗基础设施的改善和疾病意识宣传活动的加强，新兴国家提供了巨大的成长机会。然而，先进检测技术的高成本以及与性病检测相关的社会文化耻辱等因素可能会阻碍成长并阻碍在保守地区的广泛采用。技术创新的前景在于透过生物技术的进步加强快速检测方法、提高检测精度并降低成本。此外，将人工智慧和机器学习纳入诊断过程有可能提高临床环境中的资料准确性和业务效率，从而彻底改变市场交付。透过与医疗保健提供者和技术公司的策略合作，公司可以从扩大服务欠缺地区的访问和可见性中受益。由于不断变化的医疗保健优先事项和技术进步所驱动的市场动态具有动态性，因此持续的市场研究对于利用新机会和克服固有挑战至关重要。

主要市场统计
基准年[2023] 16.3亿美元
预计年份 [2024] 17.4亿美元
预测年份 [2030] 26.9亿美元
复合年增长率（%） 7.41%

市场动态：快速发展的 CT/NG 检测市场的关键市场洞察

CT/NG 检测市场正因供需的动态互动而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球性传染感染流行率不断上升
    • 提高对未经治疗的感染疾病后果的认识
    • 对照护现场(POC) 测试设备的需求不断增长
  • 市场限制因素
    • 与先进诊断设备相关的高成本
  • 市场机会
    • 政府推动性健康教育的倡议
    • 整合自动化系统以提高工作流程效率
  • 市场挑战
    • 透过 CT/NG 检测发现抗生素抗药性菌株

波特五力：驾驭 CT/NG 检测市场的策略工具

波特五力框架是了解 CT/NG 侦测市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对CT/NG检测市场的影响

外部宏观环境因素在塑造CT/NG检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解CT/NG检测市场的竞争状况

CT/NG 测试市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵CT/NG检查市场供应商绩效评估

FPNV定位矩阵是评估CT/NG检查市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘 CT/NG 检测市场的成功之路

CT/NG 检测市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球性行为感染传染病的盛行率不断上升
      • 提高对未经治疗的感染疾病影响的认识
      • 对照护现场(POC) 测试设备的需求不断增长
    • 抑制因素
      • 与先进诊断设备相关的高成本
    • 机会
      • 政府推动性教育的努力
      • 整合自动化系统以提高工作流程效率
    • 任务
      • 透过 CT/NG 检测发现抗生素抗药性细菌
  • 市场区隔分析
    • 产品：快速部署仪器和分析仪以提供一致的结果
    • 测试类型：CT/NG PoC测试越来越流行
    • 技术：基于聚合酵素链锁反应(PCR) 的 CT/NG 测试的发展，将准确性置于成本和速度之上
    • 最终使用者：医院和诊所就地检验的普及
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 CT/NG 检查市场：依产品分类

  • 检测方法和套件
  • 测量设备和分析设备

第七章 按测试类型分類的 CT/NG 检查市场

  • 实验室筛检
  • 概念验证测试

第八章 CT/NG 检查市场：依技术分类

  • 免疫诊断
  • 恒温核酸增幅技术
  • 聚合酵素链锁反应

第 9 章 CT/NG 检查市场：依最终使用者划分

  • 临床实验室
  • 医院/诊所

第十章 北美、南美CT/NG检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区CT/NG检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲CT/NG检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • binx health 宣布与 Afaxys 达成策略性供应协议，将性健康检测范围扩大到全国数千家诊所。
    • Bio-Rad 推出 Exact Diagnostics CT/NG 和 STI 运作控制
    • 雅培 (Abbott) 获得 FDA 批准，可在性行为感染病例上升的情况下同时检测四种常见性性行为感染
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Binx Health, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioneer Corporation
  • Danaher Corporation
  • ELITech Group SAS
  • F. Hoffmann-La Roche Ltd.
  • Geneproof AS
  • Genetic Signatures Ltd.
  • Goffin Molecular Technologies BV
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • Microbiologics, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Operon SA
  • PerkinElmer Inc.
  • QIAGEN NV
  • Sansure Biotech Inc.
  • Seegene, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tianlong Technology Co., Ltd.
  • Vircell SL
  • Visby Medical, Inc.
Product Code: MRR-777F3B3232BF

The CT/NG Testing Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.74 billion in 2024, and is projected to grow at a CAGR of 7.41%, to USD 2.69 billion by 2030.

The CT/NG testing market, encompassing Chlamydia trachomatis and Neisseria gonorrhoeae screening, has gained prominence due to rising STD incidences and heightened public health awareness. These bacterial infections are crucial testing targets as untreated infections can lead to severe reproductive health issues. The necessity of CT/NG testing stems from its significance in early diagnosis and prevention, directly influencing healthcare cost reductions and promoting public health safety. Predominantly applied in hospitals, clinics, and diagnostic labs, these tests cater to sexually active populations, with increasing adoption in home-testing kits due to privacy and convenience factors. Market growth is significantly fueled by technological advancements in molecular diagnostics, governmental health initiatives, and rising demand for comprehensive sexual health products. Key growth opportunities are centered around the development of cost-effective and highly sensitive point-of-care testing devices. Delving into regional perspectives, developing countries offer substantial growth windows due to emerging healthcare infrastructures and increasing disease awareness campaigns. However, growth is challenged by factors like high costs of advanced testing technologies and socio-cultural stigmas associated with STD testing, potentially hindering widespread acceptance in conservative regions. Innovation prospects lie in the enhancement of rapid testing methods, improving detection accuracy, and cost reductions through biotechnology advancements. Furthermore, integrating artificial intelligence and machine learning in diagnostic processes may revolutionize market offerings by improving data accuracy and operational efficiencies in clinical settings. Businesses can benefit from strategic collaborations with healthcare providers and technology firms to expand access and awareness across under-penetrated regions. The CT/NG testing market is underlined by its dynamic nature, dictated by shifting healthcare priorities and technological progression, making continual market research and innovation essential for capitalizing on emerging opportunities and overcoming inherent challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.74 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 7.41%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CT/NG Testing Market

The CT/NG Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of STIs worldwide
    • Growing awareness about the consequences of untreated infections
    • Rising need for point-of-care (POC) testing devices
  • Market Restraints
    • High costs associated with advanced diagnostic equipment
  • Market Opportunities
    • Government initiatives for promoting sexual health education
    • Integration of automation systems to enhance workflow efficiency
  • Market Challenges
    • Emergence of antibiotic-resistant strains by CT/NG testing

Porter's Five Forces: A Strategic Tool for Navigating the CT/NG Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CT/NG Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CT/NG Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CT/NG Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CT/NG Testing Market

A detailed market share analysis in the CT/NG Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CT/NG Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CT/NG Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the CT/NG Testing Market

A strategic analysis of the CT/NG Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the CT/NG Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, Danaher Corporation, ELITech Group SAS, F. Hoffmann-La Roche Ltd., Geneproof A.S., Genetic Signatures Ltd., Goffin Molecular Technologies B.V., Hologic, Inc., Meridian Bioscience Inc., Microbiologics, Inc., Molbio Diagnostics Pvt. Ltd., Operon S.A., PerkinElmer Inc., QIAGEN N.V., Sansure Biotech Inc., Seegene, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tianlong Technology Co., Ltd., Vircell S.L., and Visby Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the CT/NG Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Assays & Kits and Instruments & Analyzers.
  • Based on Testing Type, market is studied across Lab Tests and PoC Tests.
  • Based on Technology, market is studied across Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology, and Polymerase Chain Reaction.
  • Based on End User, market is studied across Clinical Laboratories and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of STIs worldwide
      • 5.1.1.2. Growing awareness about the consequences of untreated infections
      • 5.1.1.3. Rising need for point-of-care (POC) testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with advanced diagnostic equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives for promoting sexual health education
      • 5.1.3.2. Integration of automation systems to enhance workflow efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Emergence of antibiotic-resistant strains by CT/NG testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rapid adoption of instruments and analyzers for providing consistent results
    • 5.2.2. Testing Type: Gaining popularity of PoC tests for CT/NG
    • 5.2.3. Technology: Advancing Polymerase Chain Reaction (PCR)-based CT/NG testing for prioritizing accuracy over cost and speed
    • 5.2.4. End User: Popularity of point-of-care testing for hospital and clinic settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. CT/NG Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Assays & Kits
  • 6.3. Instruments & Analyzers

7. CT/NG Testing Market, by Testing Type

  • 7.1. Introduction
  • 7.2. Lab Tests
  • 7.3. PoC Tests

8. CT/NG Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Immunodiagnostics
  • 8.3. Isothermal Nucleic Acid Amplification Technology
  • 8.4. Polymerase Chain Reaction

9. CT/NG Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals & Clinics

10. Americas CT/NG Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CT/NG Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CT/NG Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. binx health Announces Strategic Supply Agreement with Afaxys to Expand Sexual Health Test Access to Thousands of Clinics Nationally
    • 13.3.2. Bio-Rad Launches Exact Diagnostics CT/NG, STI Run Controls
    • 13.3.3. Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. Binx Health, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bioneer Corporation
  • 6. Danaher Corporation
  • 7. ELITech Group SAS
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Geneproof A.S.
  • 10. Genetic Signatures Ltd.
  • 11. Goffin Molecular Technologies B.V.
  • 12. Hologic, Inc.
  • 13. Meridian Bioscience Inc.
  • 14. Microbiologics, Inc.
  • 15. Molbio Diagnostics Pvt. Ltd.
  • 16. Operon S.A.
  • 17. PerkinElmer Inc.
  • 18. QIAGEN N.V.
  • 19. Sansure Biotech Inc.
  • 20. Seegene, Inc.
  • 21. Siemens Healthineers AG
  • 22. Thermo Fisher Scientific Inc.
  • 23. Tianlong Technology Co., Ltd.
  • 24. Vircell S.L.
  • 25. Visby Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. CT/NG TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CT/NG TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CT/NG TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CT/NG TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CT/NG TESTING MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CT/NG TESTING MARKET SIZE, BY POC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CT/NG TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CT/NG TESTING MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CT/NG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CT/NG TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023